Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00457457
Status:
COMPLETED
Last Update Posted:
2018-12-19
First Post:
2007-04-05
Brief Title:
Study the Effects of Different Doses of UK-369003 in Men With Lower Urinary Tract Symptoms
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multi-center Randomized Parallel Group Double-blind Placebo Controlled Proof of Concept and Dose Ranging Study With an Active Control to Assess the Efficacy and SafetyTolerability of UK-369003 Immediate Release IR and Modified Release MR in the Treatment of Men With Lower Urinary Tract Symptoms LUTS With and Without Erectile Dysfunction ED
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 12 week study in which different doses and formulations of UK-369003 will be administered to patients with a diagnosis of enlarged prostate Patients will complete a series of questionnaires before during and after treatment to assess if UK-369003 has improved their urinary symptoms and erectile function There will be several blood samples taken during the study to asses the level of drug in the blood and correlate it with the responses to the questionnaires
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None